Bridgebio Pharma Inc (BBIO US)

Analysis

Health Care • United States

Bridgebio Pharma, Inc. operates as a bio technology company. The Company focuses on development of medicines for genetic diseases. Bridgebio Pharma serves patients worldwide.

Refresh

Company Presentation • 09 Sep 2026 19:00

Corporate presentation

Company Presentation • 30 Aug 2026 19:00

Corporate presentation

Company Presentation • 10 Aug 2026 19:00

Corporate presentation

Company Presentation • 28 Jun 2026 19:00

Conference presentation

Company Presentation • 03 Jun 2026 19:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00